Seyed Jalal Hosseinimehr Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2021	Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer.
1/2018	99mTc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice.
5/2017	99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting.
1/2017	Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging.
5/2016	Nuclear medicine for imaging of epithelial ovarian cancer.
2/2014	An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
11/2013	A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors.
9/2012	Radioimmunotherapy with ¹³¹I-bevacizumab as a specific molecule for cells with overexpression of the vascular endothelial growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Jalal Hosseinimehr Research Topics

Disease

77	Neoplasms (Cancer) 11/2023 - 12/2009
10	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2017
9	Wounds and Injuries (Trauma) 01/2017 - 12/2008
8	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2012
7	Burns 01/2017 - 12/2008
6	Inflammation (Inflammations) 04/2024 - 12/2014
6	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2012
6	Pain (Aches) 02/2019 - 06/2010
5	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 02/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 04/2017
4	Glioma (Gliomas) 08/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 09/2021 - 09/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 07/2018 - 09/2015
3	Necrosis 06/2018 - 01/2018
2	Schizophrenia (Dementia Praecox) 03/2024 - 12/2019
2	Lung Injury 11/2022 - 09/2022
2	Carcinogenesis 01/2020 - 04/2016
2	Radiodermatitis 02/2019 - 01/2018
2	Pruritus (Itching) 02/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2014
2	Stomatitis 07/2018 - 03/2016
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2016 - 12/2009
2	Genomic Instability 06/2015 - 11/2010
2	Thyroid Neoplasms (Thyroid Cancer) 06/2014 - 01/2014
2	Thyroid Diseases (Thyroid Disease) 04/2014 - 06/2013
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Cardiotoxicity 09/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Atrophy 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 03/2021
1	Brain Neoplasms (Brain Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

26	Peptides (Polypeptides)IBA 07/2023 - 01/2017
9	Radioisotopes (Radionuclides)IBA 07/2023 - 11/2012
8	LigandsIBA 08/2022 - 02/2014
8	tricineIBA 09/2021 - 02/2014
8	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2017 - 12/2008
7	EDDA (NiEDDA)IBA 09/2021 - 02/2014
7	RadiopharmaceuticalsIBA 12/2019 - 03/2011
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 09/2012
4	leucyl- threonyl- valyl- seryl- prolyl- tryptophyl- tyrosineIBA 07/2023 - 02/2017
4	human ERBB2 proteinIBA 01/2023 - 02/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2018
4	Mefenamic Acid (Pontal)FDA Link 01/2022 - 09/2015
4	Radiation-Sensitizing AgentsIBA 01/2022 - 01/2014
3	Caspase 3 (Caspase-3)IBA 11/2022 - 06/2018
3	Therapeutic UsesIBA 04/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2021 - 01/2010
3	Ointments (Pastes)IBA 05/2020 - 07/2015
3	Atorvastatin (Lipitor)FDA Link 01/2020 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 01/2010
2	Pimozide (Orap)FDA Link 11/2023 - 01/2021
2	AntioxidantsIBA 01/2023 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 05/2018
2	Febuxostat FDA Link 11/2022 - 11/2020
2	Gliclazide (Diamicron)IBA 09/2022 - 01/2019
2	Olanzapine (Zyprexa)FDA Link 01/2022 - 12/2019
2	Testosterone (Sustanon)FDA Link 11/2021 - 06/2018
2	Itraconazole (Sporanox)FDA LinkGeneric 04/2021 - 03/2021
2	Single-Domain AntibodiesIBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 11/2020 - 05/2020
2	diphenyl (biphenyl)IBA 01/2019 - 10/2016
2	CurcuminIBA 01/2019 - 06/2014
2	ceric oxide (cerium dioxide)IBA 01/2018 - 01/2018
2	peptide AIBA 01/2018 - 01/2017
2	Radiation-Protective Agents (Radiation Protectants)IBA 09/2015 - 12/2009
2	Saline SolutionIBA 07/2015 - 06/2015
2	Nucleotide AptamersIBA 02/2014 - 11/2013
2	Bevacizumab (Avastin)FDA Link 09/2012 - 01/2010
2	SilverIBA 01/2010 - 12/2008
1	piperineIBA 04/2024
1	Serotonin ReceptorsIBA 03/2024
1	Serotonin (5 Hydroxytryptamine)IBA 03/2024
1	PiperazineIBA 11/2023
1	Peptide Receptors (Peptide Receptor)IBA 07/2023
1	sinapinic acidIBA 01/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2023
1	Xanthine OxidaseIBA 11/2022
1	Immunoglobulin FragmentsIBA 08/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Furosemide (Lasix)FDA LinkGeneric 01/2022
1	AnionsIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Cimetidine (Biomet)FDA LinkGeneric 01/2022
1	CationsIBA 01/2022
1	hippuric acidIBA 01/2022
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 04/2021
1	Estrogens (Estrogen)FDA Link 04/2021
1	N-(3-pyridylmethyl)adriamycin (YM 1)IBA 04/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2021

Therapy/Procedure

25	Radiotherapy 04/2023 - 01/2014
21	Therapeutics 07/2023 - 01/2010
8	Drug Therapy (Chemotherapy) 11/2022 - 03/2016
3	Gamma Cameras (Gamma Camera) 09/2022 - 01/2018
2	Contraindications 04/2021 - 11/2020
1	Injections 01/2023
1	Intravenous Injections 01/2023
1	Aftercare (After-Treatment) 04/2021